Results 201 to 210 of about 12,162 (244)

Partial inhibition of viral replication machinery enhances recombination in herpes simplex viruses. [PDF]

Biol Direct
Ralph-Altman M, Avhar D, Altman Y, Cohen I, Azulay H, Korner T, Sweed S, Tomer E, Kobiler O.   +8 more
europepmc   +1 more source

A Novel Protein Recovery Method via Gel Separation and Silica Columns Capable of Rapid Antigen Purification and Deep Proteomic Identification. [PDF]

Molecules
Wang D, Wu J, Zheng X, Fan Z, Li Z, Peng C, Xu B, Tong Z.   +7 more
europepmc   +1 more source

Implementation of Acupuncture Treatment in the Modern Operating Environment: Our Reply to Study by Zou X et al [Letter]. [PDF]

J Pain Res
Bhakta P, Karim HMR, Mugawar M, O'Brien B.   +3 more
europepmc   +1 more source

Mutations and structural variants arising during double-strand break repair. [PDF]

Proc Natl Acad Sci U S A
Dalin S, Webster S, Sugawara N, Wu Q, Zhang S, Macias C, Sapède E, Cui T, Liang V, Tran L, Beroukhim R, Haber JE.   +11 more
europepmc   +1 more source

[Malignant histiocytosis (histiocytic medullary reticulosis, HMR)].

Srpski arhiv za celokupno lekarstvo, 1986
E, Stojimirović, D, Milosavljević, N, Dimitrijević   +2 more
openaire   +1 more source

Correction to: The impact of high microvascular resistance on coronary wave energetics depends on coronary microvascular functionality. [PDF]

Eur Heart J Open
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hydroxymethylated Resorcinol (HMR) and Novolak-Based HMR (n-HMR) Primers to Enhance Bond Durability of Eucalyptus globulus Glulams

Journal of Adhesion Science and Technology, 2009
The effectiveness of the hydroxymethylated resorcinol (HMR) and the novolak-based HMR (n-HMR) primers to enhance bond durability of Eucalyptus globulus glulams was evaluated according to EN 391 (Delamination) and EN 392 (Shear strength) for outdoor load-bearing timber structures (Service Class 3).
Klaus Richter
exaly   +3 more sources

Inhibition of IKs channels by HMR 1556

Naunyn-Schmiedeberg's Archives of Pharmacology, 2000
Chromanol HMR 1556 [(3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)chroman-4-yl]-N-methylmethanesulfonamide], a novel inhibitor of the slow component of the delayed outward current in heart muscle cells (IKs), has been characterized in several in-vitro systems.
Heinz Gögelein, A E Busch, Andreas E Busch   +2 more
exaly   +3 more sources

Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)

Antimicrobial Agents and Chemotherapy, 1997
HMR 3647 (RU 66647) and HMR 3004 (RU 64004), two ketolides, had MICs at which 50% of the strains are inhibited (MIC50s) of 0.06 to 0.125 microg/ml and MIC90s of 16.0 microg/ml against 352 anaerobes. MIC50s and MIC90s of erythromycin, azithromycin, clarithromycin, and roxithromycin were 0.5 to 2.0 microg/ml and 32.0 to >64.0 microg/ml, respectively ...
L M, Ednie, M R, Jacobs, P C, Appelbaum
openaire   +2 more sources

Recent development in the HMR pre-combustion gas power cycle [PDF]

Energy Procedia, 2009
The focus area of the current HMR phase has been HMR process engineering and fabrication and testing of a small-scale monolith module. A new, less complicated HMR gas power cycle has been developed and benchmarked. The efficiency loss and CO2 capture are
Aasen, Knut I., Stenersen Østby, Annette, Risdal, Turid, Budd, Michael, Käka, Daniel, Werswick, Bjørnar, Wilhelmsen, Kjersti, Bruun, Tor, Berglund, Anita, Smith, Jens B.   +9 more
exaly   +2 more sources